Trial Profile
A Randomized, Open-Label, Single-Dose, Three-Period Crossover Study in Healthy Adults to Assess the Relative Bioavailability of Test and Reference Formulations of AKB-6548 Tablets and to Evaluate the Effect of Food on the Bioavailability of AKB-6548
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Nov 2018
Price :
$35
*
At a glance
- Drugs Vadadustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Akebia Therapeutics
- 06 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Apr 2015 New trial record